1 Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2018, 68(6): 394- 424. DOI: 10.3322/caac.21492.
2 Li M Q, Gan L, Song A, et al. Rethinking pulmonary toxicity in advanced non-small cell lung cancer in the era of combining anti-PD-1/PD-L1 therapy with thoracic radiotherapy[J]. Biochimica et Biophysica Acta-Reviews on Cancer, 2019, 1871(2): 323-330. DOI: 10.1016/j. bbcan.2019.02.004.
3 Yamaguchi O, Kaira K, Hashimoto K, et al. Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab[J]. Thoracic Cancer, 2019, 10(4): 992-1000. DOI: 10.1111/1759-7714.13044.
4 Jadon R, Higgins E, Hanna L, et al. A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy[J]. Radiation Oncology, 2019, 14(1): 57. DOI: 10.1186/s13014-019- 1262-8.
5 LYU L, Zhang S Z, Hu Y, et al. Invasive pituitary adenoma-derived tumor-associated fibroblasts promote tumor progression both in vitro and in vivo[J]. Experimental and Clinical Endocrinology & Diabetes, 2018, 126(4): 213-221. DOI: 10.1055/s-0043-119636.
6 Yamao T, Yamashita Y I, Yamamura K, et al. Cellular senescence, represented by expression of caveolin-1, in cancer-associated fibroblasts promotes tumor invasion in pancreatic cancer[J]. Annals of Surgical Oncology, 2019, 26(5): 1552-1559. DOI: 10.1245/s10434-019-07266-2.
7 Huang D W, Sherman B T, Lempicki R A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources[J]. Nature Protocols, 2009, 4 (1): 44-57. DOI: 10.1038/nprot.2008.211.
8 Szklarczyk D, Gable A L, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome- wide experimental datasets[J]. Nucleic Acids Research, 2019, 47(D1): D607-D613. DOI: 10.1093/nar/gky1131.
9 Tang Z F, Li C W, Kang B X, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Research, 2017, 45 (W1): W98-W102. DOI: 10.1093/nar/gkx247.
10 Thompson M K, Poortmans P, Chalmers A J, et al. Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?[J]. British Journal of Cancer, 2018, 119(4): 389-407. DOI: 10.1038/s41416-018-0201-z.
11 Park S Y, Kim J Y, Jun Y, et al. Strategies to tackle radiation resistance by penetrating cancer stem cell line of scrimmage[J]. Recent Patents on Anti-Cancer Drug Discovery, 2018, 13(1): 18-39. DOI: 10.2174/ 1574892812666171003150410.
12 Kim B M, Hong Y, Lee S, et al. Therapeutic implications for overcoming radiation resistance in cancer therapy[J]. International Journal of Molecular Sciences, 2015, 16 (11): 26880-26913. DOI: 10.3390/ijms161125991.
13 Shojaei S, Hashemi S M, Ghanbarian H, et al. Effect of mesenchymal stem cells-derived exosomes on tumor microenvironment: tumor progression versus tumor suppression[J]. Journal of Cellular Physiology, 2019, 234 (4): 3394-3409. DOI: 10.1002/jcp.27326.
14 Hao J, Zeltz C, Pintilie M, et al. Characterization of distinct populations of carcinoma-associated fibroblasts from non-small cell lung carcinoma reveals a role for ST8SIA2 in cancer cell invasion[J]. Neoplasia, 2019, 21 (5): 482-493. DOI: 10.1016/j.neo.2019.03.009.
15 Minten E V, Yu D S. DNA repair: translation to the clinic [J]. Clinical Oncology, 2019, 31(5): 303-310. DOI: 10.1016/j.clon.2019.02.007.
16 Xu F, Li X, Yan L L, et al. Autophagy promotes the repair of radiation-induced DNA damage in bone marrow hematopoietic cells via enhanced STAT3 signaling[J]. Radiation Research, 2017, 187(3): 382-396. DOI: 10.1667/RR14640.1.
17 Cornforth M N, Loucas B D. A cytogenetic profile of radiation damage[J]. Radiation Research, 2019, 191(1): 1- 19. DOI: 10.1667/RR15205.1.
18 Mishyna M, Volokh O, Danilova Y, et al. Effects of radiation damage in studies of protein-DNA complexes by cryo-EM[J]. Micron, 2017, 96: 57-64. DOI: 10.1016/ j. micron.2017.02.004.
19 Yu T, Li J, Yan M, et al. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/ S6K2 signaling pathway[J]. Oncogene, 2015, 34(4): 413- 423. DOI: 10.1038/onc.2013.574.
20 Elizalde P V, Russo R I, Chervo M F, et al. ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy[J]. Endocrine Related Cancer, 2016,23(12): T243-T257. DOI: 10.1530/ERC-16-0360.
21 Chen Y N, Ren C C, Yang L, et al. MicroRNA let7d5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1[J]. International Journal of Oncology, 2019, 54(5): 1771-1784. DOI: 10.3892/ijo.2019.4731.
22 Qin Q P, Wang S L, Tan M X, et al. Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway [J]. European Journal of Medicinal Chemistry, 2018, 158: 106-122. DOI: 10.1016/j.ejmech.2018.09.008.
23 Arai T, Okato A, Yamada Y, et al. Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC[J]. Cancer Medicine, 2018, 7(5): 1988-2002. DOI: 10.1002/ cam4.1455.
24 Zhang Q, Su R X, Shan C, et al. Non-SMC condensin I complex, subunit G (NCAPG) is a novel mitotic gene required for hepatocellular cancer cell proliferation and migration[J]. Oncology Research, 2018, 26(2): 269-276. DOI: 10.3727/096504017X15075967560980.
25 Cui F L, Hu J P, Ning S Y, et al. Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer[J]. The Prostate, 2018, 78 (16): 1299-1310. DOI: 10.1002/pros.23703.
26 Mahadevappa R, Neves H, Yuen S M, et al. DNA replication licensing protein MCM10 promotes tumor progression and is a novel prognostic biomarker and potential therapeutic target in breast cancer[J]. Cancers (Basel), 2018, 10(9): 282. DOI: 10.3390/cancers10090282.
27 Chen Y C, Chen I S, Huang G J, et al. Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells[J]. OncoTargets and Therapy, 2018, 11: 1601-1616. DOI: 10.2147/OTT.S147453.
28 Li P, Wang Q A, Wang H N. MicroRNA-204 inhibits the proliferation, migration and invasion of human lung cancer cells by targeting PCNA-1 and inhibits tumor growth in vivo[J]. International Journal of Molecular Medicine, 2019, 43(3): 1149-1156. DOI: 10.3892/ ijmm.2018.4044.
29 Hou X F, Xu L P, Song H Y, et al. ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA[J]. World Journal of Gastroenterology, 2017, 23(10): 1796-1803. DOI: 10.3748/wjg.v23.i10.1796.
30 Perez-Peña J, Corrales-Sánchez V, Amir E, et al. Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers[J]. Scientific Reports, 2017, 7(1): 17530. DOI: 10.1038/s41598-017-17836-7.